Toledo RA, Burnichon N, Cascon A, Benn DE, Bayley JP, Welander J, Tops CM, Firth H, Dwight T, Ercolino T, Mannelli M, Opocher G, Clifton-Bligh R, Gimm O, Maher ER, Robledo M, Gimenez-Roqueplo AP, Dahia PL (2017) Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13:233–247. https://doi.org/10.1038/nrendo.2016.185

Article  CAS  PubMed  Google Scholar 

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942. https://doi.org/10.1210/jc.2014-1498

Article  CAS  PubMed  Google Scholar 

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Pacak K, Nathanson KL, Wilkerson MD (2017) Comprehensive molecular characterization of Pheochromocytoma and Paraganglioma. Cancer Cell 31:181–193. https://doi.org/10.1016/j.ccell.2017.01.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crona J, Taïeb D, Pacak K (2017) New perspectives on Pheochromocytoma and Paraganglioma: toward a molecular classification. Endocr Rev 38:489–515. https://doi.org/10.1210/er.2017-00062

Article  PubMed  PubMed Central  Google Scholar 

Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K (2022) Personalized Management of Pheochromocytoma and Paraganglioma. Endocr Rev 43:199–239. https://doi.org/10.1210/endrev/bnab019

Article  PubMed  Google Scholar 

Beilan JA, Lawton A, Hajdenberg J, Rosser CJ (2013) Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol 13:22. https://doi.org/10.1186/1471-2490-13-22

Article  PubMed  PubMed Central  Google Scholar 

Martucci VL, Lorenzo ZG, Weintraub M, del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K (2015) Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol 33:167e113–167e120. https://doi.org/10.1016/j.urolonc.2014.11.017

Article  CAS  Google Scholar 

Giubellino A, Lara K, Martucci V, Huynh T, Agarwal P, Pacak K, Merino MJ (2015) Urinary bladder paragangliomas: how immunohistochemistry can assist to identify patients with SDHB germline and somatic mutations. Am J Surg Pathol 39:1488–1492. https://doi.org/10.1097/pas.0000000000000534

Article  PubMed  PubMed Central  Google Scholar 

Srirangalingam U, Banerjee A, Patki P, Peters J, George E, Chew SL, Kumar VKA, Korbonits M, Waterhouse M, Druce MR, Sahdev A, Drake WM, Akker SA (2017) Succinate dehydrogenase B (SDHB)-Associated bladder paragangliomas. Clin Genitourin Cancer 15:e131–e136. https://doi.org/10.1016/j.clgc.2016.06.006

Article  PubMed  Google Scholar 

Yu K, Ebbehøj AL, Obeid H, Vaidya A, Else T, Wachtel H, Main AM, Søndergaard E, Lehmann Christensen L, Juhlin C, Calissendorff J, Cohen DL, Bennett B, Andersen MS, Larsson C, Almeida MQ, Fishbein L, Boorjian SA, Young WF, Bancos I (2022) Presentation, management, and outcomes of urinary bladder paraganglioma: results from a Multicenter Study. J Clin Endocrinol Metab 107:2811–2821. https://doi.org/10.1210/clinem/dgac427

Article  PubMed  PubMed Central  Google Scholar 

Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, Calsina B, Gimenez-Roqueplo AP, Nölting S, Beuschlein F, Fassnacht M, Deutschbein T, Timmers H, Åkerström T, Crona J, Quinkler M, Fliedner SMJ, Liu Y, Guo J, Li X, Guo W, Hou Y, Wang C, Zhang L, Xiao Q, Liu L, Gao X, Burnichon N, Robledo M, Eisenhofer G (2020) Sino-european differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 105. https://doi.org/10.1210/clinem/dgaa502

Pang Y, Zhang J, Jiang J, Pamporaki C, Li M, Bechmann N, Meuter L, Wei Y, Huang H, Huang S, Yu X, Robledo M, Soria MJ, Zhong D, Xu S, Timmers H, Langenhuijsen JF, Chen X, Deng W, Deutschbein T, Remde H, Wang L, Yao H, Yan B, Berends AMA, Kerstens MN, Jiang Y, Crona J, Xu N, Cai H, Wen Y, Wang A, Wu J, Zhang Z, Ning J, Cheng F, Chen X, Wang J, Xie B, Chen D, Liu Y, Liu L, Pacak K, Eisenhofer G, Lenders JWM (2024) Diagnosis and management of urinary bladder paragangliomas: a sino-american-european retrospective observational study. Clin Endocrinol (Oxf). https://doi.org/10.1111/cen.15058

Article  PubMed  Google Scholar 

Li M, He Y, Pang Y, Zhang J, Feng Y, He Y, Xu X, Wei Y, Zhong D, Deng W, Wang L, Yan B, Jiang Y, Xu N, Cai H, Wen Y, Ning J, Liu Y, Gao X, Shan Z, Liu L, Teng X, Richter S, Jiang J (2023) Somatic IDH1 hotspot variants in Chinese patients with Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab 108:1215–1223. https://doi.org/10.1210/clinem/dgac653

Article  PubMed  Google Scholar 

Eisenhofer G, Klink B, Richter S, Lenders J, W,Robledo M (2017) Metabologenomics of Phaeochromocytoma and Paraganglioma: an Integrated Approach for Personalised Biochemical and Genetic Testing. The clinical biochemist. Reviews 38:69–100

Google Scholar 

Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers H, Fassnacht M, Klink B, Lodish M, Stratakis CA, Huebner A, Fliedner S, Robledo M, Sinnott RO, Januszewicz A, Pacak K, Eisenhofer G (2017) Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab 102:1122–1132. https://doi.org/10.1210/jc.2016-3829

Article  PubMed  PubMed Central  Google Scholar 

Park S, Kang SY, Kwon GY, Kwon JE, Kim SK, Kim JY, Kim CH, Kim HJ, Moon KC, Pyo JY, Park WY, Park ES, Sung JY, Sung SH, Oh YH, Lee SE, Lee W, Lee JI, Cho NH, Jung SJ, Cho MS, Cho YM, Cho HY, Cha EJ, Chae YS, Choe G, Choi YJ, Huh J, Ro JY (2017) Clinicopathologic characteristics and Mutational Status of Succinate dehydrogenase genes in Paraganglioma of the urinary bladder: a multi-institutional Korean study. Arch Pathol Lab Med 141:671–677. https://doi.org/10.5858/arpa.2016-0403-OA

Article  CAS  PubMed  Google Scholar 

Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410. https://doi.org/10.1038/ng849

Article  CAS  PubMed  Google Scholar 

Castro-Vega LJ, Buffet A, De Cubas AA, Cascón A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre O, Currás-Freixes M, Franco-Vidal V, Guillaud-Bataille M, Simian C, Morin A, Letón R, Gómez-Graña A, Pollard PJ, Rustin P, Robledo M, Favier J, Gimenez-Roqueplo AP (2014) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23:2440–2446. https://doi.org/10.1093/hmg/ddt639

Article  CAS  PubMed  Google Scholar 

Letouzé E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, Buffet A, Marcaillou C, Bertherat J, Amar L, Rustin P, De Reyniès A, Gimenez-Roqueplo AP, Favier J (2013) SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23:739–752. https://doi.org/10.1016/j.ccr.2013.04.018

Article  CAS  PubMed  Google Scholar 

Buffet A, Morin A, Castro-Vega LJ, Habarou F, Lussey-Lepoutre C, Letouzé E, Lefebvre H, Guilhem I, Haissaguerre M, Raingeard I, Padilla-Girola M, Tran T, Tchara L, Bertherat J, Amar L, Ottolenghi C, Burnichon N, Gimenez-Roqueplo AP, Favier J (2018) Germline mutations in the mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a predisposition to metastatic paragangliomas. Cancer Res 78:1914–1922. https://doi.org/10.1158/0008-5472.Can-17-2463

Article  CAS  PubMed  Google Scholar 

Hald OC, Phan Y, C,Carter CJ (2022) Urinary bladder paraganglioma with a family history of neurofibromatosis type 1 treated with partial cystectomy. British journal of hospital medicine (London, England: 2005) 83:1–3. https://doi.org/10.12968/hmed.2021.0656

Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goodie V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45:1479–1482. https://doi.org/10.1038/ng.2814

Article  CAS  PubMed  Google Scholar 

Toledo RA, Qin Y, Cheng ZM, Gao Q, Iwata S, Silva GM, Prasad ML, Ocal IT, Rao S, Aronin N, Barontini M, Bruder J, Reddick RL, Chen Y, Aguiar RC, Dahia PL (2016) Recurrent mutations of chromatin-remodeling genes and kinase receptors in Pheochromocytomas and Paragangliomas. Clin cancer Research: Official J Am Association Cancer Res 22:2301–2310. https://doi.org/10.1158/1078-0432.Ccr-15-1841

Article  CAS  Google Scholar